Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-28 @ 9:30 AM
Study NCT ID:
NCT05207904
Status:
UNKNOWN
Last Update Posted:
2022-01-26
First Post:
2021-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-12
First Submit QC Date:
None
Study First Post Date:
2022-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-12
Last Update Post Date:
2022-01-26
Last Update Post Date Type:
ACTUAL